We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-0.7%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$10.5B
AUM Growth
-$1.73B
Cap. Flow
-$1.74B
Cap. Flow %
-16.59%
Top 10 Hldgs %
73.24%
Holding
508
New
262
Increased
77
Reduced
116
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 3.02%
2 Energy 2.11%
3 Consumer Discretionary 2.02%
4 Financials 1.95%
5 Consumer Staples 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNB
426
DELISTED
Dun & Bradstreet
DNB
$322K ﹤0.01%
+2,748
New +$334K
WCN
427
Waste Connections
WCN
$42B
$321K ﹤0.01%
+4,475
New +$318K
SRCL
428
DELISTED
Stericycle Inc
SRCL
$321K ﹤0.01%
+5,486
New +$371K
PBI icon
429
Pitney Bowes
PBI
$2.39B
$319K ﹤0.01%
+29,253
New +$362K
CXW icon
430
CoreCivic
CXW
$3.19B
$316K ﹤0.01%
+16,182
New +$350K
FIS icon
431
Fidelity National Information Services
FIS
$22.1B
$286K ﹤0.01%
+2,969
New +$291K
ADBE icon
432
Adobe
ADBE
$105B
$273K ﹤0.01%
1,265
-11,203
-90% -$2.28M
ERIE icon
433
Erie Indemnity
ERIE
$13.2B
$269K ﹤0.01%
+2,288
New +$266K
L icon
434
Loews
L
$23.6B
$264K ﹤0.01%
+5,305
New +$268K
CLGX
435
DELISTED
Corelogic, Inc.
CLGX
$263K ﹤0.01%
+5,811
New +$267K
FAF icon
436
First American
FAF
$7.58B
$262K ﹤0.01%
+4,466
New +$262K
FNF icon
437
Fidelity National Financial
FNF
$13.5B
$258K ﹤0.01%
6,697
-16,489
-71% -$627K
NGD
438
DELISTED
New Gold Inc
NGD
$258K ﹤0.01%
99,537
-3,931
-4% -$11K
AGO icon
439
Assured Guaranty
AGO
$3.34B
$257K ﹤0.01%
+7,101
New +$250K
CINF icon
440
Cincinnati Financial
CINF
$27.1B
$257K ﹤0.01%
+3,457
New +$259K
KMPR icon
441
Kemper
KMPR
$1.68B
$257K ﹤0.01%
+4,506
New +$277K
RNR icon
442
RenaissanceRe
RNR
$13.4B
$257K ﹤0.01%
+1,857
New +$241K
MCY icon
443
Mercury Insurance
MCY
$6.07B
$256K ﹤0.01%
+5,583
New +$266K
AXS icon
444
AXIS Capital
AXS
$7.55B
$255K ﹤0.01%
+4,438
New +$229K
EG icon
445
Everest Group
EG
$14.4B
$255K ﹤0.01%
+992
New +$238K
WRB icon
446
W.R. Berkley
WRB
$26.6B
$255K ﹤0.01%
+11,860
New +$247K
AFG icon
447
American Financial Group
AFG
$12.1B
$254K ﹤0.01%
+2,259
New +$253K
CNA icon
448
CNA Financial
CNA
$14.1B
$254K ﹤0.01%
+5,139
New +$269K
THG icon
449
Hanover Insurance
THG
$7.98B
$253K ﹤0.01%
+2,146
New +$241K
TAHO
450
DELISTED
Tahoe Resources Inc
TAHO
$252K ﹤0.01%
53,692
-4,462
-8% -$20.4K

Similar funds

Ray Dalio's Q1 2018 Portfolio in Review

As of Q1 2018, Ray Dalio held 508 positions worth $10.5B, down 14% from $12.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Ray Dalio withdrew a net $1.74B in Q1 2018, closing 48 positions and reducing 116 holdings. Its most notable exit was Costco, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, up from 1.7% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Ray Dalio opened a new position in Biogen worth $21.1M.

  • Ray Dalio's largest Q1 2018 buy was Biogen: 77,197 shares worth $21.1M.
  • Ray Dalio added most to Newfield Exploration in Q1 2018, an estimated $44.6M increase.
  • Ray Dalio's biggest Q1 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.04B.
  • Ray Dalio fully exited Costco in Q1 2018, selling an estimated $15.6M.
  • Ray Dalio's ten largest holdings make up 73% of its $10.5B portfolio in Q1 2018.
  • Ray Dalio opened 262 new positions and closed 48 in Q1 2018.
  • Ray Dalio's portfolio value fell 14% quarter-over-quarter to $10.5B.

Based on Bridgewater Associates's 13F filing for Q1 2018, filed 15 May 2018.